Back to Top Skip to main content Skip to sub-navigation

Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2010–2018

Image of Anopheles merus . Click to open a larger version of the image. Neisseria gonorrhoeae Photo Courtesy of CDC: M Rein

Recommended Content:

Medical Surveillance Monthly Report

ABSTRACT

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2010–2018. Infections with chlamydia were the most common, followed in decreasing order of frequency by infections with genital human papillomavirus (HPV), gonorrhea, genital herpes simplex virus (HSV), and syphilis. Compared to men, women had higher rates of all STIs except for syphilis. In general, compared to their respective counterparts, younger service members, non-Hispanic blacks, soldiers, and enlisted members had higher incidence rates of STIs. During the latter half of the surveillance period, the incidence of chlamydia and gonorrhea increased among both male and female service members. Rates of syphilis increased for male service members but remained relatively stable among female service members. In contrast, the incidence of genital HPV and HSV decreased among both male and female service members. Similarities to and differences from the findings of the last MSMR update on STIs are discussed.

WHAT ARE THE NEW FINDINGS?

The incidence of chlamydia and gonorrhea increased among male and female service members in the latter half of the surveillance period, while the incidence of genital HPV and HSV decreased. Among male service members, the incidence of syphilis increased sharply between 2012 and 2018.

WHAT IS THE IMPACT ON READINESS AND FORCE HEALTH PROTECTION?

STIs can adversely impact service members’ availability and ability to perform their duties and can result in serious medical sequelae if untreated. Establishing standards for screening, testing, treatment, and reporting would likely improve efforts to detect STI-related health threats. Continued behavioral risk-reduction interventions are needed to counter the increasing incidence of STIs among service members.

BACKGROUND

Sexually transmitted infections (STIs) are relevant to the U.S. military because of their relatively high incidence, adverse impact on service members’ availability and ability to perform their duties, and potential for serious medical sequelae if untreated.1 Two of the most common bacterial STIs are Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea). Rates of chlamydia and gonorrhea have been steadily increasing in the general U.S. population among both men and women since 2000.2 A September 2017 MSMR report documented almost 180,000 incident infections of chlamydia and more than 29,000 incident infections of gonorrhea among active component U.S. military members between 2007 and 2016, with no overall decrease in incidence rates during the 10-year period.3

Another important bacterial STI is syphilis, which is caused by the bacterium Treponema pallidum. Rates of primary and secondary syphilis in the U.S. increased 72.7%, from 5.5 cases per 100,000 persons in 2013 to 9.5 cases per 100,000 persons in 2017.2 These trends are mirrored in the active component of the U.S. Armed Forces, in which the incidence of syphilis (of any type) doubled between 2007 and 2016, with most of the increase occurring among men.3 Although these 3 relatively common bacterial STIs are curable with antibiotics, there is continued concern regarding the threat of multidrug resistance.4

Common viral STIs in the U.S. include infections caused by human papillomavirus (HPV) and genital herpes simplex virus (HSV). HPVs are DNA viruses that infect basal epithelial (skin or mucosal) cells. HPV genotypes 6 and 11 are responsible for 90% of all genital wart infections.5 HSV can cause genital or oral herpes infections that are characterized by the appearance of 1 or more vesicles that can break and leave painful ulcers. Most genital herpes infections are caused by type 2 (HSV-2); however, type 1 (HSV-1), which is most often associated with oral herpes infection, is estimated to be responsible for 50% of new genital herpes infections.6 Neither HPV nor HSV viral infections are curable with antibiotics; however, suppression of recurrent herpes manifestations is attainable using antiviral medication, and there is a vaccine to prevent infection with 4 of the most common HPV serotypes. From 2007 through 2016, the overall incidence rates of genital HPV and HSV in the active component were 60.1 and 23.3 cases per 10,000 person-years (p-yrs), respectively.3

The current analysis updates the findings of previous MSMR articles on STIs among active component service members.1,3 Specifically, the current report summarizes incident cases and incidence rates of 5 of the most common STIs among active component military members during 2010–2018 by demographic and military characteristics.

METHODS

The surveillance period was 1 January 2010 through 31 December 2018. The surveillance population consisted of all active component service members of the U.S. Army, Navy, Air Force, or Marine Corps who served at any time during the period. Diagnoses of STIs were ascertained from medical administrative data and reports of notifiable medical events routinely provided to the Armed Forces Health Surveillance Branch and maintained in the Defense Medical Surveillance System for surveillance purposes. STI cases were also derived from positive laboratory records in the Health Level 7 (HL7) chemistry and microbiology databases maintained by the Navy and Marine Corps Public Health Center at the EpiData Center.

For each service member, the number of days in active military service was ascertained and then aggregated into a total for all service members during each calendar year. The resultant annual totals were expressed as p-yrs of service and used as the denominators for the calculation of annual incidence rates. Person-time that was not considered to be time at risk for each STI was excluded (i.e., the 30 days following each incident chlamydia or gonorrhea infection and all person-time following the first diagnosis, medical event report, or positive laboratory test of HSV, HPV, or syphilis).

An incident case of chlamydia was defined by having any of the following: 1) a case-defining diagnosis (Table 1) in the first or second diagnostic position of a record of an outpatient or in-theater medical encounter, 2) a confirmed notifiable disease report for chlamydia, or 3) a positive laboratory test for chlamydia (any specimen source or test type). An incident case of gonorrhea was similarly defined by having 1) a case-defining diagnosis in the first or second diagnostic position of a record of an inpatient or outpatient or in-theater encounter, 2) a confirmed notifiable disease report for gonorrhea, or 3) a positive laboratory test for gonorrhea (any specimen source or test type). For both chlamydia and gonorrhea, an individual could be counted as having a subsequent case only if there were more than 30 days between the dates on which the case-defining diagnoses were recorded.

Incident cases of HSV were identified by 1) the presence of the requisite ICD-9 or ICD-10 codes in either the first or second diagnostic positions of a record of an outpatient or in-theater encounter or 2) a positive laboratory test from a genital specimen source. Antibody tests were excluded because they do not allow for distinction between genital and oral infections. Incident cases of HPV were similarly identified by 1) the presence of the requisite ICD-9 or ICD-10 codes in either the first or second diagnostic positions of a record of an outpatient or in-theater encounter or 2) a positive laboratory test from any specimen source or test type. Outpatient encounters for HPV with evidence of an immunization for HPV within 7 days before or after the encounter date were excluded as were outpatient encounters with a procedural or Current Procedural Terminology (CPT) code indicating HPV vaccination, as such encounters were potentially related to the vaccination administration. An individual could be counted as an incident case of HSV or HPV only once during the surveillance period. Individuals who had diagnoses of HSV or HPV infection prior to the surveillance period were excluded from the analysis.

An incident case of syphilis was defined by having 1) a qualifying ICD-9 or ICD-10 code in the first, second, or third diagnostic position of a hospitalization, 2) at least 2 outpatient or in-theater encounters within 30 days of each other, with a qualifying ICD-9 or ICD-10 code in the first or second position, 3) a confirmed notifiable disease report for any type of syphilis, or 4) a record of a positive polymerase chain reaction or treponemal laboratory test. Stages of syphilis (primary, secondary, late, latent) could not be distinguished because the HL7 laboratory data do not allow for differentiation of stages and because there is a high degree of misclassification associated with the use of ICD diagnosis codes for stage determination.7,8 An individual could be considered an incident case of syphilis only once during the surveillance period; those with evidence of prior syphilis infection were excluded from the analysis.

RESULTS

Between 2010 and 2018, the number of incident chlamydia infections among active component service members was greater than that of any other single STI and approximately 3 times the total number of genital HPV infections—the next most frequently identified STI during this period (Table 2). With the exception of syphilis, the overall incidence rates of all STIs were markedly higher among women than men. For chlamydia, gonorrhea, and syphilis, overall incidence rates were highest among those aged 24 years or younger and decreased with advancing age. However, overall rates of genital HSV and HPV were highest among those aged 20–24 years and those aged 25–29 years. Rates of all STIs were highest among non-Hispanic black service members compared to other race/ethnicity groups. For chlamydia, gonorrhea, and genital HSV, overall rates were highest among members of the Army. The overall incidence rate of syphilis was highest among Navy members, and the overall rate of genital HPV was highest among Air Force members. Compared to their respective counterparts, enlisted service members and those with lower levels of educational achievement tended to have higher overall rates for all STIs. Married service members had the lowest incidence rates of all 5 STIs compared to service members who were single and never married or of other/unknown marital status. Overall rates of chlamydia, gonorrhea, and syphilis were highest among those working in motor transport. In contrast, genital HPV rates were highest among those in healthcare occupations, and the highest rates of genital HSV were among those working in communications/intelligence, health care, or motor transport (Table 2). Patterns of incidence rates over time for each specific STI are described in the subsections below.

Chlamydia

During the surveillance period, annual incidence rates of chlamydia among service women generally ranged from 3 to 5 times the rates among men. Annual rates among men and women combined increased 56.6% between 2013 and 2018, with rates among both sexes peaking in 2018 (men: 175.1 per 10,000 p-yrs; women: 513.1 per 10,000 p-yrs) (Figure 1). In both sexes, the increase was primarily attributed to service members in the youngest age groups (less than 25 years among women; less than 30 years among men) (data not shown).

Among service women in each race/ethnicity group, annual rates of chlamydia increased among those under 25 years of age during 2013–2018 but remained relatively stable among those aged 25–34 years and among those aged 35 years or older (Figure 2). Among service men, annual rates of chlamydia increased between 2013 and 2018 in all age and race/ethnicity groups less than 35 years old but remained relatively stable among those in older age groups (Figure 3).

Genital HPV

The annual incidence rates of diagnoses of genital HPV decreased 51.9% among all active component service members from the beginning to the end of the surveillance period, with the most dramatic decrease occurring among women (Figure 4). There was a dip in the overall incidence of genital HPV in 2013 at 55.6 cases per 10,000 p-yrs, but the lowest point was reached in 2018 at 41.9 cases per 10,000 p-yrs. Incidence rates among female service members declined by almost 50% during the surveillance period, from a high of 372.1 cases per 10,000 p-yrs in 2010 to a low of 191.3 cases per 10,000 p-yrs in 2018 (Figure 4). Rates among men also decreased, from 45.5 per 10,000 p-yrs in 2010 to 16.0 per 10,000 p-yrs in 2018. The decrease in the incidence among both men and women was attributable to a decrease in the rates in the youngest age groups (less than 30 years) (Figures 5, 6). Age-specific time trends were similar when stratified by race/ethnicity, in that the incidence of genital HPV decreased in the youngest age groups among service members in all race/ethnicity groups (data not shown).

Gonorrhea

Between 2012 and 2018, annual incidence rates of gonorrhea increased by 55.3% and 33.6% among male and female service members, respectively (Figure 7). The increase in gonorrhea incidence between 2012 and 2018 was primarily driven by increases among women less than 25 years of age and among men less than 30 years of age (Figures 8, 9). The ratio of the annual incidence rate for women compared to men was 2.1 in 2010 but dropped to 1.4 in 2018. The incidence of gonorrhea increased during the surveillance period among all race/ethnicities, with the sharpest increase occurring among non-Hispanic Black service members between 2015 and 2018 (data not shown). The incidence increased during the surveillance period among the youngest age groups for service members in all race/ethnicity groups (data not shown).

Genital HSV

Incidence rates of genital herpes infections decreased slightly from 25.3 to 20.4 per 10,000 p-yrs during the surveillance period. Rates among female service members ranged from a high of 74.8 per 10,000 p-yrs in 2010 to 64.0 per 10,000 p-yrs in 2018. Men’s rates also peaked in 2010 (17.2 per 10,000 p-yrs) and reached their lowest point in 2018 (12.1 per 10,000 p-yrs) (Figure 10). Among women, the highest rates were observed among those less than 25 years of age, while the highest rates among men were among those aged 25–29 or 20–24 years (data not shown). The incidence of genital HSV decreased among all age groups during the surveillance period, although the sharpest decrease occurred among service members aged 30 years and older (data not shown). In addition, the incidence decreased among all race/ethnicities during the surveillance period except for Asian/Pacific Islanders. The decrease was most notable among non-Hispanic Black service members, who saw a decline from a high of 49.0 per 10,000 p-yrs in 2011 to a low of 37.4 per 10,000 p-yrs in 2018 (data not shown).

Syphilis

The incidence rate for syphilis in the last year of the surveillance period was 2.7 times that observed in 2010, with the increase primarily driven by cases identified in male service members (Figure 11). Rates of syphilis steadily increased among men during the surveillance period, with the sharpest increase occurring after 2012. Among women, rates increased from 2010 to 2014 but leveled off during the remainder of the surveillance period. The incidence of syphilis increased with advancing age among both men and women (data not shown). Among men, the pattern of increasing incidence by age was consistent among all race/ethnicity groups; there were not enough cases to evaluate associations with age and race/ethnicity among women (data not shown).

EDITORIAL COMMENT

During the last few years of the surveillance period, the annual incidence rates of chlamydia, gonorrhea, and syphilis increased among male service members, and the annual incidence of chlamydia and gonorrhea increased among female service members. Rates of syphilis remained relatively stable among female service members during the latter half of the surveillance period. In contrast, the incidence of genital HPV and HSV decreased among both male and female service members. Overall rates of STIs were higher among women when compared to men for HPV, HSV, gonorrhea, and chlamydia. Syphilis was the only STI in this analysis for which the incidence was, on average, higher among male compared to female service members.

Higher rates of most STIs among women can likely be attributed to implementation of the services’ screening programs for STIs among female service members as they enter active service and during the subsequent annual screenings for women under age 26. Because asymptomatic infection with chlamydia, gonorrhea, or HPV is common among sexually active women, widespread screening may result in sustained high numbers of infections diagnosed among young women. Rates of chlamydia and gonorrhea increased among both male and female service members during the latter half of the surveillance period. This trend is similar to the increasing rates in the civilian population. In the U.S., rates of chlamydia have been increasing among both men and women since 2000, and rates of gonorrhea have been increasing among both sexes since 2013.2 These increases in both the civilian and military populations could reflect true increases in the incidence of infections as well as improved screening coverage in men, particularly extragental screening in men who have sex with men.9 

No data on sexual risk behaviors were available in this study, but prior surveys of military personnel have indicated high levels of risk behaviors. The 2015 Department of Defense Health Related Behaviors Survey (HRBS) documented that 19.4% of respondents reported having more than 1 sex partner in the past year and that 36.7% reported sex with a new partner in the past year without using a condom; these percentages were almost double those reported from the previous survey in 2011.10 A pattern of continued increases in such reported risk behaviors would further suggest a true increase in the incidence of STIs like chlamydia and gonorrhea; however, data from the 2018 HRBS were not available at the time of this report.

The downward trend in genital HPV incidence rates observed during the surveillance period may be related to the introduction of the HPV vaccine for women and girls in 2006 and for men in 2010. Among civilian women aged 14–24 years, cervical/vaginal prevalence of HPV types 6, 11, 16, and 18 decreased by approximately 6% from the period 2003–2006 to 2009–2012.8 The HPV vaccine is currently not a mandatory vaccine for military service, but it is encouraged and offered to service members. Because the HPV vaccine (Gardasil®) is approved for use among males and females beginning at age 11 years, it is possible that an increasing number of members who entered military service during the surveillance period may have been vaccinated for HPV prior to entering service. This prior vaccination may account for the decrease in genital HPV incidence during the surveillance period even as the number of service women initiating HPV vaccine is decreasing.11However, the reason for the increased incidence of genital HPV after 2013 among women aged 30 years and older is unknown.

The trends in the incidence of HSV and syphilis in the U.S. military are also similar to what is observed in the civilian population. Data from the Centers for Disease Control and Prevention’s (CDC’s) National Health and Nutrition Examination Survey indicate that the seroprevalence of both HSV-1 and HSV-2 has decreased in the U.S. population since 1999.2 In contrast, the incidence of primary and secondary syphilis reported to the CDC has increased markedly since 2001, with men accounting for the majority of cases.2,12

This report has several limitations that should be considered when interpreting the results. First, the results presented here are not comparable with the prior MSMR update on STIs because the case definition employed in the 2017 analysis did not include the results of laboratory tests for any of the STIs. In addition, the case definition for syphilis was revised for the current analysis to limit misclassification of diagnoses recorded during outpatient encounters and of diagnoses by syphilis stage.7,8 However, diagnoses of STIs may still be incorrectly coded. For example, STI-specific “rule out” diagnoses or vaccinations (e.g., HPV vaccination) may be reported with STI-specific diagnostic codes, which would result in an overestimate of STI incidence. Cases of syphilis, genital HSV, and genital HPV based solely on laboratory test results are considered “suspect” because the lab test results cannot distinguish between active and chronic infections. However, because incident cases of these STIs were identified based on the first qualifying encounter or laboratory result, the likelihood is high that most such cases are acute and not chronic.

STI cases may not be captured if coded in the medical record using symptom codes (e.g., urethritis) rather than STI-specific codes. In addition, the counts of STI diagnoses reported here may underestimate the actual numbers of diagnoses because some affected service members may be diagnosed and treated through non-reimbursed, non-military care providers (e.g., county health departments or family planning centers) or in deployed settings (e.g., overseas training exercises, combat operations, or aboard ships). Laboratory tests that are performed in a Purchased CareThe TRICARE Health Program is often referred to as purchased care. It is the services we “purchase” through the managed care support contracts.purchased care setting, a shipboard facility, a battalion aid station, or an in-theater facility were not captured in the current analysis.

For some STIs, the detection of prevalent infections may occur long after the initial infections. As a result, changes in incidence rates reflect, at least in part, temporal changes in case ascertainment, such as a shift to more aggressive screening. The lack of standard practices across the services and their installations regarding screening, testing, treatment, and reporting complicate interpretations of differences between services, military and demographic subgroups, and locations. Establishing screening, testing, treatment, and reporting standards across the services and ensuring adherence to such standards would likely improve efforts to detect and characterize STI-related health threats. In addition, continued behavioral risk-reduction interventions are needed to counter the increasing incidence of STIs among military service members.

Author affiliations: Armed Forces Health Surveillance Branch, Silver Spring, MD (Dr. Stahlman and Ms. Oetting)

Acknowledgment: The authors thank Mr. Nicolas Seliga, MPH, with the Navy and Marine Corps Public Health Center, Norfolk, VA, for providing the laboratory data.

 

REFERENCES

1. Armed Forces Health Surveillance Branch. Sexually transmitted infections, active component, U.S. Armed Forces, 2000–2012. MSMR. 2013;20(2):5–10.

2. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2017. Atlanta: U.S. Department of Health and Human Services; 2018. https://www.cdc.gov/std/stats17/2017-STD-Surveillance-Report_CDC-clearance-9.10.18.pdf. Accessed 16 February 2019.

3. Stahlman S, Oetting AA. Sexually transmitted infections, active component, U.S. Armed Forces, 2007–2016. MSMR. 2017;24(9):15–22.

4. Krupp K, Madhivanan P. Antibiotic resistance in prevalent bacterial and protozoan sexually transmitted infections. Indian J Sex Transm Dis AIDS. 2015;36(1):3–8.

5. National Cancer Institute. HPV and Cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-fact-sheet. Accessed 13 February 2019.

6. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis. 2003;30(10):797–800.

7. Garges E, Stahlman S, Jordan N, Clark LL. P3.69 Administrative medical encounter data and medical event reports for syphilis surveillance: a cautionary tale. Sex Transm Infect. 2017;93:A118.

8. Armed Forces Health Surveillance Branch. Use of ICD-10 code A51.31 (condyloma latum) for identifying cases of secondary syphilis. MSMR. 2017;24(9):23.

9. Centers for Disease Control and Prevention. 2017 Sexually Transmitted Disease Surveillance. National Profile Overview: Chlamydia. https://www.cdc.gov/std/stats17/chlamydia.htm. Accessed 16 February 2019.

10. Meadows SO, Engel CO, Collins RL, et al. 2015 Health Related Behaviors Survey. Sexual Behavior and Health among Active-Duty Service Members. RAND Corporation Research Brief. https://www.rand.org/pubs/research_briefs/RB9955z5.html. Accessed 16 February 2019.

11. Clark LL, Stahlman S, and Taubman SB. Human papillomavirus vaccine initiation, coverage, and completion rates among U.S. active component service members, 2007–2017. MSMR. 2018;25(9):9–14.

12. Centers for Disease Control and Prevention. 2017 Sexually Transmitted Disease Surveillance. National Profile Overview: Syphilis. https://www.cdc.gov/std/stats17/Syphilis.htm. Accessed 16 February 2019.



You also may be interested in...

Obesity prevalence among active component service members prior to and during the COVID-19 pandemic, January 2018–July 2021

Article
3/1/2022

This study examined monthly prevalence of obesity and exercise in active component U.S. military members prior to and during the COVID-19 pandemic. These results suggest that the COVID-19 pandemic had a small effect on the trend of obesity in the active component U.S. military and that obesity prevalence continues to increase.

Recommended Content:

Medical Surveillance Monthly Report

Update: Malaria, U.S. Armed Forces, 2021

Article
3/1/2022

Malaria infection remains an important health threat to U.S. service members who are located in endemic areas because of long-term duty assignments, participation in shorter-term contingency operations, or personal travel. In 2021, a total of 20 service members were diagnosed with or reported to have malaria.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Medical Separation from Service Among Incident Cases of Osteoarthritis and Spondylosis, Active Component, U.S. Armed Forces, 2016–2020

Article
3/1/2022
Marines hike to the next training location during Exercise Baccarat in Aveyron, Occitanie, France, Oct.16, 2021. Exercise Baccarat is a three-week joint exercise with Marines and the French Foreign Legion that challenges forces with physical and tactical training. Photo By: Marine Corps Lance Cpl. Jennifer Reyes

Osteoarthritis (OA) is the most common adult joint disease and predominantly involves the weight-bearing joints. This condition, including spondylosis (OA of the spine), results in significant disability and resource utilization and is a leading cause of medical separation from military service.

Recommended Content:

Medical Surveillance Monthly Report

Brief Report: Refractive Surgery Trends at Tri-Service Refractive Surgery Centers and the Impact of the COVID-19 Pandemic, Fiscal Years 2000–2020

Article
3/1/2022
Cadet Saverio Macrina, U.S. Military Academy West Point, receives corneal cross-linking procedure at Fort Belvoir Community Hospital, Va., Nov. 21, 2016. (DoD photo by Reese Brown)

Since the official introduction of laser refractive surgery into clinical practice throughout the Military Health System (MHS) in fiscal year 2000, these techniques have been heavily implemented in the tri-service community to better equip and improve the readiness of the U.S. military force.

Recommended Content:

Medical Surveillance Monthly Report

Brief report: Using syndromic surveillance to monitor MIS-C associated with COVID-19 in Military Health System beneficiaries

Article
3/1/2022
Air Force 1st Lt. Anthony Albina, a critical care nurse assigned to Joint Base Andrews, Md., checks a patient’s breathing and heart rate during an intubation procedure while supporting COVID-19 response operations in Cleveland, Jan. 20, 2022.

SARS CoV-2 and the illness it causes, COVID-19, have exacted a heavy toll on the global community. Most of the identified disease has been in the elderly and adults. The goal of this analysis was to ascertain if user-built ESSENCE queries applied to records of outpatient MHS health care encounters are capable of detecting MIS-C cases that have not been identified or reported by local public health departments.

Recommended Content:

Medical Surveillance Monthly Report

Diagnosis of hepatitis C infection and cascade of care in the active component, U.S. Armed Forces, 2020

Article
2/1/2022
Navy Petty Officer 2nd Class Cecil Dorse, left, and Navy Petty Officer 3rd Class Janet Rosas test blood samples aboard the Military Sealift Command hospital ship USNS Comfort while the ship is in New York City in support of the nation’s COVID-19 response, April 6, 2020. Photo By: Navy Petty Officer 2nd Class Sara Eshleman

Hepatitis C virus (HCV) infection rates are rising in the U.S. despite widely available tools to identify and effectively treat nearly all of these cases. This cross-sectional study aimed to use laboratory data to evaluate the prevalence of HCV diagnoses among active component U.S. military service members.

Recommended Content:

Medical Surveillance Monthly Report

A new approach to categorization of ocular injury among U.S. Armed Forces

Article
2/1/2022
Air Force and Space Force Surgeon General Lt. Gen. Dorothy Hogg receives an eye exam from Air Force Reserve Maj. Leslie Wilderson at Joint Base Anacostia-Bolling, Washington, D.C., March 26, 2021. Photo By: Air Force Staff Sgt. Kayla White

Ocular injuries present an ongoing threat to readiness and retention of service members. This report describes a new approach to categorizing ocular injury using Military Health System data, the application of an algorithm to a dataset, and the verification of the results using an audit of clinical data.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance snapshot: Health care burden attributable to osteoarthritis and spondylosis, active component, U.S. Armed Forces, 2016–2020

Article
2/1/2022
Air Force security forces trainees climb a hill during a 3-mile ruck march to commemorate National Police Week at Joint Base San Antonio, May 13, 2019. Photo By: Sarayuth Pinthong, Air Force

This snapshot summarizes the total numbers of inpatient and outpatient encounters with an OA or spondylosis diagnosis in the first diagnostic position and the total numbers of unique individuals affected by these conditions during the same 5-year surveillance period.

Recommended Content:

Medical Surveillance Monthly Report

Description of a COVID-19 Beta Variant Outbreak, Joint Base Lewis-McChord, WA, February–March 2021

Article
1/1/2022
U.S. Army Soldiers from 1-17th Infantry Battalion, 2nd Stryker Brigade, 2nd Infantry Division, clear an objective during the training exercise Bayonet Focus 19-02 at Yakima Training Center, Wash., May 6, 2019. Bayonet Focus is a training exercise designed to assess Soldiers’ ability to preform tasks and complete objectives under conditions experienced during combat situations. (U.S. Army photo by Spc. Angel Ruszkiewicz)

This report describes an outbreak of SARS-CoV-2, the causative agent of COVID-19, that peaked during 21–26 February 2021 and was tied to a single military training event. A total of 143 laboratory-confirmed cases were identified.

Recommended Content:

Medical Surveillance Monthly Report

COVID-19 and Depressive Symptoms Among Active Component U.S. Service Members, January 2019–July 2021

Article
1/1/2022
With the holiday season upon us, the cold, dark days that winter brings, and the social distancing and movement restrictions brought about by COVID-19, it’s not uncommon for people to feel depressed. (Photo by Erin Bolling)

This study examined the rates of depressive symptoms in active component U.S. service members prior to and during the COVID-19 pandemic and evaluated whether SARS-CoV-2 test results (positive or negative) were associated with self-reported depressive symptoms.

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Lengths of Hospital Stays for Service Members Diagnosed with Sepsis, Active Component, U.S. Armed Forces, 2011–2020

Article
1/1/2022
The (left to right) Senior Airman Austin Shrewsbury, 88th Diagnostics and Therapeutic Squadron medical laboratory technician, works with student, Airman 1st Class Taylor Altman, 88th Diagnostics and Therapeutic Squadron medical laboratory technician, to identify bacteria of patient’s cultures inside the microbiology laboratory at Wright-Patterson Air Force Base medical center June 30, 2017.

Sepsis is a serious and life-threatening organ dysfunction caused by a dysregulated host response to infection. In the U.S., sepsis is a leading cause of in-hospital mortality and 1 of the most expensive conditions treated in U.S. hospitals.

Recommended Content:

Medical Surveillance Monthly Report

Incident COVID-19 Infections, Active and Reserve Components, Jan. 1, 2020–Aug. 31, 2021

Article
12/1/2021
U.S. Marines with Marine Rotational Force - Darwin receive a second COVID-19 test during quarantine on Royal Australian Air Force Base Darwin in Darwin, NT, Australia, June 12, 2020. The COVID-19 test was administered to each Marine after arriving from California. All Marines will be quarantined for 14 days and undergo an additional test before quarantine release. No Marines tested positive for COVID-19. The U.S. Marine Corps and Australian Defence Force service members are working together to ensure the safety of the local community. (U.S. Marine Corps photo by Lance Cpl. Natalie Greenwood)

Incident COVID-19 Infections, Active and Reserve Components, 1 January 2020–31 August 2021

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Donovanosis Among Active Component Service Members, U.S. Armed Forces, 2011–2020

Article
12/1/2021
This photomicrograph of a tissue sample extracted from a lesion in the inguinal region of the female granuloma inguinale, or Donovanosis patient, depicted in PHIL 6431, revealed a white blood cell (WBC) that contained the pathognomonic finding of Donovan bodies, which were encapsulated, Gram-negative rods, representing the responsible bacterium Klebsiella granulomatis, formerly known as Calymmatobacterium granulomatis. Photo credit: CDC/ Susan Lindsley

Recommended Content:

Medical Surveillance Monthly Report

Update: Osteoarthritis and Spondylosis, Active Component, U.S. Armed Forces, 2016–2020

Article
12/1/2021
Osteoarthritis (OA) knee . film x-ray AP ( anterior - posterior ) and lateral view of knee show narrow joint space, osteophyte ( spur ), subchondral sclerosis, knee joint inflammation. Photo by: iStockPhoto

Osteoarthritis (OA), the most com­mon adult joint disease, is primarily a degenerative disorder of the entire joint organ, including the subchondral bone, synovium, and periarticular structures (e.g., tendons, ligaments, bursae). Spondylosis, often referred to as OA of the spine, is characterized by degenerative changes in the vertebral discs, joints, and vertebral bodies.

Recommended Content:

Medical Surveillance Monthly Report

Update: Plant Dermatitis Among Active Component Service Members, U.S. Armed Forces, 2010–2020

Article
11/1/2021
Poison ivy (Toxicodendron radicans)

Plant dermatitis is an allergic inflammatory skin reaction in response to the oils of poisonous plants. In the U.S., the most common dermatitis-causing plant genus is the Toxicodendron (formerly Rhus). Approximately 50%–75% of the U.S. adult population are susceptible to skin reactions upon exposure to Toxicodendron oil or oleoresin, called urushiol.

Recommended Content:

Medical Surveillance Monthly Report
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 16

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.